ProKidney Corp (PROK) Historical Volatility

Tracking PROK historical volatility helps you see how much ProKidney Corp's stock price has actually moved over past periods, giving you a baseline to judge whether current option premiums are fair, cheap, or expensive. While implied volatility tells you what the market expects, ProKidney Corp's HV tells you what really happened. Use our scanner to monitor PROK 30 day historical volatility alongside longer lookback windows and spot the moments when realized and implied diverge.

Historical volatility is the annualized standard deviation of an underlying's past returns, typically measured over rolling windows like 10, 20, 30, or 60 days. The PROK 30 day historical volatility is one of the most widely watched readings because it balances responsiveness with stability. Comparing ProKidney Corp's HV to its implied volatility reveals the volatility risk premium — when IV sits well above HV, option sellers tend to have an edge; when HV runs hot relative to IV, buyers may be underpaying for movement.

ProKidney Corp., a clinical-stage biotechnology, engages in developing cellular therapy candidates. It is developing Renal Autologous Cell Therapy, an autologous homologous cell admixture that is in a Phase III development program, as well as Phase II clinical trials for the treatment of moderate to severe diabetic kidney disease; and Phase I clinical trial for patients with congenital anomalies of the kidney and urinary tract. The company was founded in 2015 and is headquartered in Winston-Salem, North Carolina.

Sizing a long premium trade, modeling a covered call, or hunting volatility arbitrage all come back to one question: how much has the stock actually moved? Our scanner puts ProKidney Corp's historical volatility side-by-side with implied readings across every lookback window, so you can see exactly where PROK HV is running hot, cold, or in line. Make the PROK 30 day historical volatility — and every other window — work for your edge instead of against it.